Discontinuation rates similar between HAART regimens
1 October 2001. Related: Antiretrovirals.
2001
African patients with non-B subtypes respond to HAART
1 October 2001. Related: Antiretrovirals.
Resistance to nevirapine differs by HIV-1 subtype
1 October 2001. Related: Pregnancy, Drug resistance.
Oxihumate may boost immune system in HIV-positive patients
1 October 2001. Related: Other news.
Aminoperazine shows promise in enhancing immune response of HIV patients
1 October 2001. Related: Treatment strategies.
Dressed to kill? A review of why antiviral CD8 T lymphocytes fail to prevent progressive immunodeficiency in HIV-1 infection
1 October 2001. Related: Basic science and immunology.
Interleukin-2 with dual nucleoside therapy
1 October 2001. Related: Treatment strategies.
Lymphocyte receptor pattern heightens susceptibility of GI mucosa to HIV
1 October 2001. Related: Basic science and immunology.
Acceleration of increasing plasma HIV RNA load signals incipient progression
1 October 2001. Related: Basic science and immunology.
NIMH scientists find new details of HIV viral reproduction process
1 October 2001. Related: Basic science and immunology.
AIDS virus’s ability to mimic other infections weakens the body’s defences against disease
1 October 2001. Related: Basic science and immunology.
FDA requests changes in product information for all antiretrovirals
1 October 2001. Related: Side effects.
Dihydrotestosterone for HAART-associated breast enlargement in men
1 October 2001. Related: Side effects, Lipodystrophy and metabolic complications.
Osteopenia seen in testosterone-deficient women with AIDS wasting
1 October 2001. Related: Women's health, Side effects, Lipodystrophy and metabolic complications.
Corticosteroids linked to HIV-associated osteonecrosis
1 October 2001. Related: Side effects.
Dietary factors, metabolic abnormalities and fat redistribution
1 October 2001. Related: Side effects, Lipodystrophy and metabolic complications.
High incidence of reduced bone density found in HIV positive people
1 October 2001. Related: Side effects.
Puberty delayed in vertically infected children
1 October 2001. Related: Paediatric care.
Metabolic abnormalities in children treated and not treated with protease inhibitors
1 October 2001. Related: Paediatric care.
Early treatment with interferon alpha-2b can prevent chronic liver disease in those with hepatitis C
1 October 2001. Related: Hepatitis coinfection.
Harmless hepatitis-type virus seems to extend lives of HIV-positive individuals
1 October 2001. Related: Hepatitis coinfection.
Adefovir dipivoxil promising for lamivudine-resistant HBV in HIV-1 infected patients
1 October 2001. Related: Hepatitis coinfection.
Severe hepatic injury common after HAART initiation
1 October 2001. Related: Side effects, Hepatitis coinfection.
AIDS-related lymphoma responds best to chemotherapy/HAART combination
1 October 2001. Related: Coinfections and complications.
AIDS increases risk of non-AIDS-related cancers
1 October 2001. Related: Cancer and HIV.
Imiquimod and drug resistant herpes simplex
1 October 2001. Related: Coinfections and complications.
Can low-dose shark cartilage shrink KS?
1 October 2001. Related: Coinfections and complications, Cancer and HIV.
Respiratory failure in PCP patients can recur after HAART initiated
1 October 2001. Related: Coinfections and complications.
Valcyte receives Dutch regulatory approval for treatment of AIDS-related CMV retinitis
1 October 2001. Related: Coinfections and complications.
Immune Response Corp to drop study of HIV drug Remune
1 October 2001. Related: Other news.
Asthma prevalence high in HIV-positive men
1 October 2001. Related: Other news.
Volume 2 Number 8 October 2001 PDF
1 October 2001. Related: PDFs.
Drug companies’ spending on advertising double research and development spending in 2000
1 September 2001. Related: Treatment access.
Nigeria to launch AIDS treatment program
1 September 2001. Related: Treatment access.
Europe moves to speed up approval of new drugs
1 September 2001. Related: Other news.
Deal allows developing countries free access to journals
1 September 2001. Related: Other news.
Trials of Immune Response Corp’s AIDS vaccine Remune may end after Pfizer drops financial support
1 September 2001. Related: Vaccines and microbicides.
1st IAS Conference on HIV Pathogenesis and Treatment, July 8-11 2001, Buenos Aires, Argentina
1 September 2001. Related: Conference reports.
Lipodystrophy and metabolic complications
1 September 2001. Related: Conference reports, Side effects.
Lipodystrophy and metabolic disturbances
1 September 2001. Related: Conference reports, Side effects, Lipodystrophy and metabolic complications.
Pharmacology at 1st IAS
1 September 2001. Related: Conference reports, PK and drug interactions.
Drug-drug interactions
1 September 2001. Related: Conference reports, PK and drug interactions.
Immunotherapy at the 1st IAS conference
1 September 2001. Related: Treatment strategies.
Entry inhibitor updates from the 1st IAS
1 September 2001. Related: Conference reports, Antiretrovirals.
Structured treatment interruptions (STIs) and structured intermittent therapy (SITs)
1 September 2001. Related: Conference reports.
Adverse events with antiretrovirals
1 September 2001. Related: Conference reports, Side effects.
Durable HIV treatment benefit despite low-level viraemia: reassessing definitions of success or failure
1 September 2001. Related: Antiretrovirals.
Anticancer drug 9-nitrocamptothecin (9NC) inhibits HIV-1 replication
1 September 2001. Related: Antiretrovirals.
Updated US Public Health Service guidelines for the management of occupational exposures to HBV, HCV and HIV and recommendations for postexposure prophylaxis (PEP)
1 September 2001. Related: Guidelines.
Carnitine for high triglycerides
1 September 2001. Related: Side effects.
Does efavirenz cause breast enlargement?
1 September 2001. Related: Side effects, Lipodystrophy and metabolic complications.
Fat malabsorption common cause of diarrhoea in HIV-positive patients
1 September 2001. Related: Side effects.
Dietary supplements can help with nelfinavir-related diarrhoea
1 September 2001. Related: Side effects.
HCV coinfection may have role in changes in body composition in HIV patients
1 September 2001. Related: Side effects, Lipodystrophy and metabolic complications, Hepatitis coinfection.
Interferon shows some benefit in preventing AIDS-related opportunistic infections
1 September 2001. Related: Coinfections and complications.
AIDS research today: 20 views
1 September 2001. Related: On the web.
Volume 2 Number 7 August/September 2001 PDF
1 September 2001. Related: PDFs.
5th International Workshop on HIV Drug Resistance, 4-8 June 2001, Scottsdale, Arizona
30 July 2001. Related: Conference reports.
Anti-HIV immune responses and partial viral suppression
30 July 2001. Related: Conference reports, Drug resistance.
HIV resistance, phenotypic drug susceptibility and viral fitness
30 July 2001. Related: Conference reports, Drug resistance.
SWATCH – alternating antiretroviral regimens
30 July 2001. Related: Conference reports, Drug resistance.
Structured treatments interruptions
30 July 2001. Related: Conference reports, Drug resistance.
Importance of additional active drugs for NNRTI-naive patients using NNRTI-based salvage regimens
30 July 2001. Related: Conference reports, Drug resistance.
NNRTI and PI drug plasma levels are as critical as drug sensitivity in achieving treatment success in antiretroviral experienced patients
30 July 2001. Related: Conference reports, Drug resistance.
Increased prevalence of transmission of drug resistant HIV and reduced response in newly infected subjects in nine US cities
30 July 2001. Related: Conference reports, Drug resistance.